PT-141

 PT-141 (bremelanotide) is a melanocortin-pathway peptide used in research to investigate receptor-mediated neuroendocrine signaling, especially across MC1R/MC4R-linked pathways.

• Research class: Melanocortin receptor agonist peptide (PT-141 / bremelanotide).

• Primary research purpose: Studying melanocortin signaling pharmacology and downstream neurochemical pathway effects.

• Common research endpoints: Receptor-binding potency profiles (MC1R, MC4R, MC3R, MC5R, MC2R), pathway activation markers, and signal-transduction responses.

For research use only. Not for therapeutic or diagnostic applications.

COA provided by Mrs. Goodlife